The Top 100 Healthcare Technology Companies of 2021



The Healthcare Technology Report is pleased to announce The Top 100 Healthcare Technology Companies of 2021. This year’s awardees comprise a broad range of companies from well-known names like Johnson & Johnson, 3M Health Care, and Illumina to relatively newer but rapidly growing enterprises such as GRAIL, Capsule, and DNA Script. The diverse range of sophisticated products and services offered through these companies — from digital pharmacies to holistic patient care and AI-powered robotics to digital healthcare payments — have not only led to the modernization of the healthcare sector but also to a brighter future where healthcare is democratized for all.

Advancements in healthcare, whether through data and communications, research and clinical trials, medical devices or consumer offerings, have also helped to create an environment where more promising care alternatives are possible. The pioneering companies selected for this year’s list have one thing in common: they are revolutionizing the way we live, and the way we navigate one of the most important factors for us all: our health. The following awardees were nominated and selected based on a thorough evaluation process. Among the key criteria considered were product or service quality, customer adoption, management team caliber, organizational effectiveness, and company growth among other factors.

Please join us in recognizing The Top 100 Healthcare Technology Companies of 2021.

Source: The Healthcare Technology Report – view original article

Pulse Biosciences25. Pulse Biosciences
Category: Medical Devices

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients. The company’s proprietary Nano-Pulse Stimulation™(NPS) technology offers a unique cellular-specific mechanism that has extensive utility across several medical specialties.

The CellFX System is the company’s first commercial product to harness the distinctive advantages of NPS technology to address a range of common dermatologic conditions that have generally been challenging to treat with traditional methods. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model deployed through a proprietary cloud-based infrastructure.

Pulse Biosciences was founded in 2014, born from the groundbreaking research of nano-pulsed technology breakthroughs discovered by leading bioelectric researchers at Old Dominion University and the University of Southern California. The company is headquartered in Hayward, California and to date, Pulse Biosciences holds more than 112 issued licensed patents worldwide. This year, the CellFX System received U.S. FDA clearance, the CE Mark for commercialization in the European Union and a Medical Device License from Health Canada.